Luke Dannenberg, PhD profile page

Dr. Luke Dannenberg joined Oligo Factory in January 2025 from the Dana-Farber Cancer Institute (DFCI), where he served as the accelerator business development director for diagnostics. Prior to DFCI, he served in multiple leadership positions at Roche Diagnostics, including lifecycle leader for the Tissue CDx portfolio at Foundation Medicine and lifecycle leader for the NGS Sample Prep Reagents portfolio at Roche Sequencing Solutions. Dannenberg has also worked abroad with Roche Diagnostics in Amman, Jordan and Dubai, UAE. He started his industry career in 2006 at NimbleGen Systems. He holds a PhD in biochemistry from the Indiana University School of Medicine and a BSc in molecular biology from the University of Wisconsin-La Crosse.